Ready for a successful 2021.

WILD Geschäftsführung 50 years of experience have taught us one thing above all: Only those who look ahead, remain optimistic and get to work when others are still waiting will stay in the fast lane.

Even as a “Best Ager”, WILD has set its sights on one thing above all for the coming year: Investing in the future and being ready for the next challenges of the markets. In order to be able to respond to short-term changes, the ability to learn, speed and agility are crucial. Thanks to the expansion of digital communication and the high level of development expertise combined with intensive involvement of the WIN partner network, the system partner is ideally positioned.

Negative effects of the Corona pandemic for the 2021 business are currently not expected. “On the contrary, there is a great need to catch up in the field of medical technology. Supported by new customer projects, we expect growth of around 9 percent,” says CFO Michael Wratschko confidently. “It is becoming apparent that customers will increasingly invest in the development of new products with WILD as a strong technology partner at their side. In in-vitro diagnostics and medical technology, for example, the trend is toward point-of-care devices. In laboratory analytics, customers are striving to integrate functions that were previously performed in laboratories in several steps on different instruments into a single device. To achieve this, a high level of expertise in miniaturization, automation and system integration, as well as very good knowledge of standards, is a prerequisite. WILD brings all of this to the table and also has not only creative ideas, but also a modular system kit that makes it easy for customers to get started at any stage of the project.